Cargando…
Development and immunological assessment of VLP-based immunogens exposing the membrane-proximal region of the HIV-1 gp41 protein
BACKGROUND: The membrane-proximal external region (MPER) of HIV-1 gp41 is particularly conserved and target for the potent broadly neutralizing monoclonal antibodies (bnMAbs) 2F5, 4E10 and 10E8. Epitope focusing and stabilization present promising strategies to enhance the quality of immune response...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4256929/ https://www.ncbi.nlm.nih.gov/pubmed/25160824 http://dx.doi.org/10.1186/s12929-014-0079-x |
_version_ | 1782347651000303616 |
---|---|
author | Benen, Thomas D Tonks, Paul Kliche, Alexander Kapzan, Ruth Heeney, Jonathan L Wagner, Ralf |
author_facet | Benen, Thomas D Tonks, Paul Kliche, Alexander Kapzan, Ruth Heeney, Jonathan L Wagner, Ralf |
author_sort | Benen, Thomas D |
collection | PubMed |
description | BACKGROUND: The membrane-proximal external region (MPER) of HIV-1 gp41 is particularly conserved and target for the potent broadly neutralizing monoclonal antibodies (bnMAbs) 2F5, 4E10 and 10E8. Epitope focusing and stabilization present promising strategies to enhance the quality of immune responses to specific epitopes. RESULTS: The aim of this work was to design and evaluate novel immunogens based on the gp41 MPER with the potential to elicit cross-clade neutralizing antibodies. For that purpose, gp41 was truncated N-terminally in order to dispose immunodominant, non-neutralizing sites and enhance the exposure of conserved regions. To stabilize a trimeric conformation, heterologous GCN4 and HA2 zipper domains were fused based on an in silico “best-fit” model to the protein’s amino terminus. Cell surface exposure of resulting proteins and their selective binding to bnMAbs 2F5 and 4E10 could be shown by cytometric analyses. Incorporation into VLPs and preservation of antigenic structures were verified by electron microscopy, and the oligomeric state was successfully stabilized by zipper domains. These gp41 immunogens were evaluated for antigenicity in an immunization study in rabbits primed with homologous DNA expression plasmids and boosted with virus-like particle (VLP) proteins. Low titers of anti-MPER antibodies were measured by IgG ELISA, and low neutralizing activity could be detected against a clade C and B viral isolate in sera. CONCLUSIONS: Thus, although neutralizing titers were very moderate, induction of cross-clade neutralizing antibodies seems possible following immunization with MPER-focusing immunogens. However, further refinement of MPER presentation and immunogenicity is clearly needed to induce substantial neutralization responses to these epitopes. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12929-014-0079-x) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4256929 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-42569292014-12-06 Development and immunological assessment of VLP-based immunogens exposing the membrane-proximal region of the HIV-1 gp41 protein Benen, Thomas D Tonks, Paul Kliche, Alexander Kapzan, Ruth Heeney, Jonathan L Wagner, Ralf J Biomed Sci Research BACKGROUND: The membrane-proximal external region (MPER) of HIV-1 gp41 is particularly conserved and target for the potent broadly neutralizing monoclonal antibodies (bnMAbs) 2F5, 4E10 and 10E8. Epitope focusing and stabilization present promising strategies to enhance the quality of immune responses to specific epitopes. RESULTS: The aim of this work was to design and evaluate novel immunogens based on the gp41 MPER with the potential to elicit cross-clade neutralizing antibodies. For that purpose, gp41 was truncated N-terminally in order to dispose immunodominant, non-neutralizing sites and enhance the exposure of conserved regions. To stabilize a trimeric conformation, heterologous GCN4 and HA2 zipper domains were fused based on an in silico “best-fit” model to the protein’s amino terminus. Cell surface exposure of resulting proteins and their selective binding to bnMAbs 2F5 and 4E10 could be shown by cytometric analyses. Incorporation into VLPs and preservation of antigenic structures were verified by electron microscopy, and the oligomeric state was successfully stabilized by zipper domains. These gp41 immunogens were evaluated for antigenicity in an immunization study in rabbits primed with homologous DNA expression plasmids and boosted with virus-like particle (VLP) proteins. Low titers of anti-MPER antibodies were measured by IgG ELISA, and low neutralizing activity could be detected against a clade C and B viral isolate in sera. CONCLUSIONS: Thus, although neutralizing titers were very moderate, induction of cross-clade neutralizing antibodies seems possible following immunization with MPER-focusing immunogens. However, further refinement of MPER presentation and immunogenicity is clearly needed to induce substantial neutralization responses to these epitopes. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12929-014-0079-x) contains supplementary material, which is available to authorized users. BioMed Central 2014-08-27 /pmc/articles/PMC4256929/ /pubmed/25160824 http://dx.doi.org/10.1186/s12929-014-0079-x Text en © Benen et al.; licensee BioMed Central 2014 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Benen, Thomas D Tonks, Paul Kliche, Alexander Kapzan, Ruth Heeney, Jonathan L Wagner, Ralf Development and immunological assessment of VLP-based immunogens exposing the membrane-proximal region of the HIV-1 gp41 protein |
title | Development and immunological assessment of VLP-based immunogens exposing the membrane-proximal region of the HIV-1 gp41 protein |
title_full | Development and immunological assessment of VLP-based immunogens exposing the membrane-proximal region of the HIV-1 gp41 protein |
title_fullStr | Development and immunological assessment of VLP-based immunogens exposing the membrane-proximal region of the HIV-1 gp41 protein |
title_full_unstemmed | Development and immunological assessment of VLP-based immunogens exposing the membrane-proximal region of the HIV-1 gp41 protein |
title_short | Development and immunological assessment of VLP-based immunogens exposing the membrane-proximal region of the HIV-1 gp41 protein |
title_sort | development and immunological assessment of vlp-based immunogens exposing the membrane-proximal region of the hiv-1 gp41 protein |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4256929/ https://www.ncbi.nlm.nih.gov/pubmed/25160824 http://dx.doi.org/10.1186/s12929-014-0079-x |
work_keys_str_mv | AT benenthomasd developmentandimmunologicalassessmentofvlpbasedimmunogensexposingthemembraneproximalregionofthehiv1gp41protein AT tonkspaul developmentandimmunologicalassessmentofvlpbasedimmunogensexposingthemembraneproximalregionofthehiv1gp41protein AT klichealexander developmentandimmunologicalassessmentofvlpbasedimmunogensexposingthemembraneproximalregionofthehiv1gp41protein AT kapzanruth developmentandimmunologicalassessmentofvlpbasedimmunogensexposingthemembraneproximalregionofthehiv1gp41protein AT heeneyjonathanl developmentandimmunologicalassessmentofvlpbasedimmunogensexposingthemembraneproximalregionofthehiv1gp41protein AT wagnerralf developmentandimmunologicalassessmentofvlpbasedimmunogensexposingthemembraneproximalregionofthehiv1gp41protein |